Fenofibrate

C-C motif chemokine ligand 2 ; Homo sapiens







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31708994 Senescent synovial fibroblasts accumulate prematurely in rheumatoid arthritis tissues and display an enhanced inflammatory phenotype. 2019 1
2 26136131 Comparison of the effects of hypolipidemic treatment on monocyte proinflammatory cytokine release in men and women with type 2 diabetes and atherogenic dyslipidemia. 2015 3
3 26617775 Fenofibrate, a PPARĪ± agonist, protect proximal tubular cells from albumin-bound fatty acids induced apoptosis via the activation of NF-kB. 2015 1
4 23043158 Therapeutic effects of PPARĪ± agonists on diabetic retinopathy in type 1 diabetes models. 2013 Jan 1
5 22228203 A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network. 2012 Mar 2
6 21276586 Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia. 2011 Apr 1 1
7 20360622 Metabolic and monocyte-suppressing actions of fenofibrate in patients with mixed dyslipidemia and early glucose metabolism disturbances. 2010 Jan-Feb 1
8 19825152 TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate. 2009 Oct 12 1
9 19132243 High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cells. 2008 Dec 1
10 17631136 Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. 2007 Jul 1
11 16600694 Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells. 2006 Jun 1
12 15772519 Effect of monthly atorvastatin and fenofibrate treatment on monocyte chemoattractant protein-1 release in patients with primary mixed dyslipidemia. 2005 Apr 2
13 15985720 Monocyte suppressing action of fenofibrate. 2005 May-Jun 3
14 12756509 Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia. 2003 Jul 3
15 12816176 Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia. 2003 Jun 2
16 11382718 Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. 2001 May 29 1